Subscribe to Search results

In a letter from Dr Walford, it was emphasised that 90% of all post-transfusion hepatitis in the USA and elsewhere was caused by non-A, non-B hepatitis viruses. It was described as rapidly fatal.

Published on:

An article titled "Non-A, Non-B Hepatitis Associated With Chronic Liver Disease in a Haemodialysis Unit" in The Lancet described NANB hepatitis as relating to "high frequency of persistent hepatic dysfunction".

Published on:

In an article titled "Transfusion-associated hepatitis not due to viral hepatitis type A or B" it was recognised NANB hepatitis was the cause of many cases of post-transfusion hepatitis in comparison to other types.

Published on:

An article in the The Lancet titled "Non-A Non-B Hepatitis Post Transfusion Hepatitis", contained data that pointed to NANBH being the cause of a substantial cases of post-transfusion hepatitis.

Published on:

An article in The Yale Journal of Biology and Medicine titled, "Non-A, Non-B Hepatitis", outlined the role of NANB of subsequent development of chronic liver disease.

Published on:

An article in Gastroenterology titled, "Development of Chronic Liver Disease after Acute Non-A, Non-B Post-Transfusion Hepatitis: Role of _-globulin prophylaxis in its prevention", outlined the role of NANB of subsequent development of chronic liver disease.

Published on:

Article in Gastroenterology titled, "Post-transfusion hepatitis: The role of hepatitis B antibody", outlined the role of NANB of subsequent development of chronic liver disease.

Published on:

An article titled, "Non-A/Non-B Hepatitis: A Review and Interim Report of an Ongoing Prospective Study", outlined the role of NANB of subsequent development of chronic liver disease.

Published on:

In an article in The British Medical Journal titled, "Post-transfusion non-A, non-B hepatitis in the Netherlands", the significance of NANBH and the need for a test for it was outlined.

Published on:

Peter Burgin, senior executive officer at the Department of Health, was recruited to carry out the formal internal review on self-sufficiency. The material parts of the job were set out in the job description.

Published on:

Richard Gutowski, Head of Blood Policy, expressed the view external resources were needed to finalise the report on self-sufficiency.

Published on:

The version of the self-sufficiency report as amended by Dianthus Medical Ltd was sent to Richard Gutowski, Head of Blood Policy..

Published on:

Peter Burgin carried out a number of interviews as part of his review on self-sufficiency, including Dr Terry Snape, Blood Products Laboratory. Dr Snape prepared various documents for Peter Burgin prior to his visit.

Published on:

Charles Lister wrote to Zubeda Seedat setting out the remit of the work done by Peter Burgin on self-sufficiency.

Published on:

Richard Gutowski, Head of Blood Policy, considered that external consultants were required to finish the self-sufficiency report and that it would be helpful to have a subsidiary report on when HCV was first identified.

Published on:

Richard Gutowski, Head of Blood Policy, wrote to his director confirming their agreement that a medical drafter redraft the Burgin report in a "more robust form".

Published on:

Richard Gutowski, Head of Blood Policy, explained to his director he would have liked to involve Dr Hugh Nicholas in an assessment of whether the decisions made at the time on self-sufficiency stood up in light of the contemporary knowledge and information available, but he was unavailable.

Published on:

Charles Lister expressed regret that he had not been able to take the drafting of the Self-Sufficiency Report forward between December 2022 and May 2003.

Published on:

Melanie Johnson replied to a letter from Peter Mossman explaining that she had asked her officials to conclude the review on self-sufficiency as soon as possible.

Published on:

John Hutton replied to a letter from Lord Owen advising that officials had been asked to conclude the review on self-sufficiency as soon as practicable.

Published on: